SCHEMBL946696

SCHEMBL946696

NC1=NC(Cc2ccccc2)(c2cccc(Br)c2)N=C1S

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 4/20 0.46
NPSR1 Q6W5P4 1/20 0.40
CTSD P07339 1/20 0.37
IDO1 P14902 2/20 0.36
AGXT P21549 2/20 0.36
MEN1 O00255 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
APP P05067 2/20 0.34
TAAR1 Q96RJ0 1/20 0.34
MAOB P27338 1/20 0.34
KDM1A O60341 2/20 0.33
RCOR1 Q9UKL0 2/20 0.33
FLT1 P17948 1/20 0.32
KDR P35968 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL932777 0.84 BACE1 (0.65) BACE1NPSR1CTSDIDO1AGXT
SCHEMBL931863 0.81 BACE1 (0.46) BACE1NPSR1CTSDIDO1AGXT
SCHEMBL6894146 0.71 BACE1 (0.56) BACE1NPSR1MEN1KMT2AAPP
SCHEMBL932144 0.68 BACE1 (0.46) BACE1CTSDMEN1KMT2AMAOB
SCHEMBL932309 0.66 BACE1 (0.44) BACE1CTSDAPPKDM1ARCOR1
SCHEMBL931210 0.66 BACE1 (0.47) BACE1CTSDMEN1KMT2AAPP
SCHEMBL932350 0.65 BACE1 (0.50) BACE1CTSD
SCHEMBL931852 0.64 BACE1 (0.49) BACE1CTSD
SCHEMBL2460997 0.64 NPSR1 (0.41) NPSR1IDO1AGXTMEN1LMNA
SCHEMBL14010658 0.63 UTS2R (0.40) BACE1NPSR1CTSDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011002408-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed
WO-2011002408-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed